ORIC Pharmaceuticals
ORIC
ORIC Pharmaceuticals (ORIC) earnings history
Most recent quarter
- Fiscal period
- Q3 2025
- Period end
- Sep 30, 2025
- EPS actual
- −$0.33
- EPS estimate
- −$0.41
- EPS surprise
- +18.56%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Nov 13, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q3 2025 | Nov 13, 2025 | −$0.41 | −$0.33 | +18.56% | $0.00 | SEC |
| Q2 2025 | Aug 12, 2025 | −$0.44 | −$0.47 | −6.09% | $0.00 | SEC |
| Q1 2025 | May 5, 2025 | −$0.51 | −$0.42 | +17.82% | $0.00 | SEC |
| Q4 2024 | Feb 18, 2025 | −$0.50 | −$0.51 | −1.92% | $0.00 | SEC |
| Q3 2024 | Nov 12, 2024 | −$0.48 | −$0.49 | −2.47% | $0.00 | SEC |
| Q2 2024 | Aug 12, 2024 | −$0.41 | −$0.45 | −9.12% | $0.00 | SEC |
| Q1 2024 | May 6, 2024 | −$0.43 | −$0.37 | +13.79% | $0.00 | SEC |
| Q4 2023 | Mar 11, 2024 | −$0.48 | −$0.49 | −2.62% | $0.00 | SEC |
| Q3 2023 | Nov 6, 2023 | −$0.46 | −$0.44 | +4.80% | $0.00 | SEC |
| Q2 2023 | Aug 10, 2023 | −$0.57 | −$0.50 | +12.11% | $0.00 | SEC |
| Q1 2023 | May 8, 2023 | −$0.54 | −$0.53 | +1.92% | $0.00 | SEC |
| Q4 2022 | Mar 16, 2023 | −$0.55 | −$0.52 | +5.11% | $0.00 | SEC |
| Q3 2022 | Nov 7, 2022 | −$0.55 | −$0.63 | −13.92% | $0.00 | SEC |
| Q2 2022 | Aug 11, 2022 | −$0.60 | −$0.51 | +15.01% | $0.00 | SEC |
| Q1 2022 | May 9, 2022 | −$0.57 | −$0.59 | −3.85% | $0.00 | SEC |
| Q4 2021 | Mar 21, 2022 | −$0.57 | −$0.58 | −2.58% | $0.00 | SEC |
| Q3 2021 | Nov 8, 2021 | −$0.58 | −$0.47 | +19.30% | $0.00 | SEC |
| Q2 2021 | Aug 10, 2021 | −$0.49 | −$0.57 | −15.76% | $0.00 | SEC |
| Q1 2021 | May 6, 2021 | −$0.48 | −$0.45 | +6.74% | $0.00 | SEC |
| Q4 2020 | Mar 23, 2021 | −$0.41 | −$0.84 | −104.48% | $0.00 | — |
Quarterly revenue
Frequently asked questions
When did ORIC Pharmaceuticals (ORIC) last report earnings?
ORIC Pharmaceuticals last reported on Nov 13, 2025, covering fiscal Q3 2025.
Did ORIC beat earnings estimates?
Yes. ORIC Pharmaceuticals reported EPS of −$0.33 for Q3 2025 against a −$0.41 estimate — a 18.56% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.